Irreversible airway obstruction in childhood asthma? A clinician's viewpoint

Peter König1

  • 1Division of Pediatric Pulmonary/Allergy, University of Missouri-Columbia, One Hospital Drive, Room M668, Columbia, MO 65212, USA. KonigP@health.missouri.edu

Pediatric Pulmonology
|March 29, 2002
PubMed

Insights

Childhood asthma typically involves reversible airway obstruction. However, some children develop irreversible obstruction, potentially due to inflammation and airway remodeling, necessitating further research into small airway obstruction.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Asthma Research

Background:

  • Childhood asthma is often characterized by reversible airway obstruction.
  • However, some children may develop irreversible airway obstruction, possibly linked to airway remodeling from inflammation.
  • Concerns exist regarding progressive irreversible obstruction in untreated asthma patients.

Purpose of the Study:

  • To evaluate the development of progressive irreversible airway obstruction in children with asthma.
  • To investigate factors contributing to pulmonary function deterioration in pediatric asthma.
  • To highlight the need for further research into small airway obstruction in childhood asthma.

Main Methods:

  • Review of existing studies on childhood asthma and airway obstruction.
  • Analysis of findings from the Childhood Asthma Management Program (CAMP) study, a randomized placebo-controlled trial.
  • Focus on pulmonary function tests, particularly forced expiratory volume in 1 sec (FEV(1)).

Main Results:

  • The CAMP study did not demonstrate progressive irreversible airway obstruction in pediatric asthma patients.
  • Pulmonary function deterioration occurs in some children, potentially linked to insufficient anti-inflammatory treatment or adrenergic therapy.
  • Previous research predominantly focused on large airway obstruction (FEV(1)).

Conclusions:

  • Progressive irreversible airway obstruction is not a universal outcome in childhood asthma, contrary to some claims.
  • Inadequate anti-inflammatory treatment and possibly maintenance adrenergic treatment may contribute to pulmonary function decline.
  • Further investigation into small airway obstruction in pediatric asthma is warranted.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...